Skip to main content

Find Clinical Trials

Home
Conditions
Hematologic Neoplasms

Clinical trial condition

Hematologic Neoplasms

Explore clinical trials studying Hematologic Neoplasms. Study availability and eligibility vary by location and protocol.

1,046 public trials 269 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Neoplasms trial results

Terminated

Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis

NCT01437787

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematopoietic Neoplasm, +3 more
Locations: Investigational Site Number 840014 Scottsdale, Arizona, United States

Investigational Site Number 840001 La Jolla, California, United States

Investigational Site Number 840012 La Jolla, California, United States

Investigational Site Number 840006 Los Angeles, California, United States

View all 101 locations

View Trial Details

Terminated

Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

NCT05101213

Conditions: Adenoviridae Infections, Adenovirus Infection, BK Virus Infection, +15 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Terminated

Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis

NCT04438382

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +5 more
Locations: Northwestern University Chicago, Illinois, United States

Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States

Bronson Battle Creek Battle Creek, Michigan, United States

Mercy Health Saint Mary's Grand Rapids, Michigan, United States

View all 18 locations

View Trial Details

Suspended

Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

NCT02962661

Conditions: Cardiomyopathies, Cardiomyopathy, Cardiovascular Diseases, +9 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Withdrawn

CD70.CAR for CD70+ Lymphoma, Myeloma and Solid Tumors

NCT07297160

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hematologic Diseases, +23 more
Locations: Texas Children's Hospital Houston, Texas, United States

The Methodist Hospital Houston, Texas, United States

View Trial Details

Withdrawn

64Cu-DOTA-pembrolizumab PET for the Study of PD1 Expression

NCT04605614

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +4 more
Locations: Not specified

View Trial Details